THAR: Tharimmune, Inc. Stock

SIC 2834 – Pharmaceutical Preparations

Valuation
Market Cap ($M) 2.55
Enterprise Value ($M) -5.88
Book Value ($M) 7.05
Book Value / Share 8.97
Price / Book 0.36
NCAV ($M) 7.05
NCAV / Share 8.97
Price / NCAV 0.36

Profitability (mra)
Return on Invested Capital (ROIC) -1.26
Return on Assets (ROA) -1.93
Return on Equity (ROE) -2.90

Liquidity (mrq)
Quick Ratio 4.84
Current Ratio 4.84

Balance Sheet (mrq) ($M)
Current Assets 8.89
Assets 8.89
Liabilities 1.84
Debt n/a
Equity n/a

Income Statement (mra) ($M)
Revenue 0.00
Operating Income -9.46
Net Income -9.32
Earnings Per Share Diluted n/a
Earnings Per Share Basic n/a

Cash Flow Statement (mra) ($M)
Cash From Operations -7.30
Cash from Investing 0.00
Cash from Financing 11.72

(click for more detail)

File Date Form Activist 13D/G Investors Ownership
(%)
Change
(%)
02-14 13G/A Tang Capital Partners Lp 0.00 -100.00

Top 13F Investors Shares
(1000)
Change
(%)
Value
($1000)
Change
(%)

(click for more detail)

Date Insider Trades Code Shares Value

(click for more detail)

File Date Form SEC Filings
2024-05-09 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q
2024-02-23 10-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-K
2023-11-07 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 10-Q

(click for more detail)
Short Volume
Market Date Short Volume Total Volume Short Volume Ratio
2024-07-26 2,283 19,259 11.85
2024-07-25 4,679 15,027 31.14
2024-07-24 11,801 90,358 13.06
2024-07-23 9,635 34,437 27.98
2024-07-22 3,656 22,180 16.48

(click for more detail)

Similar Companies
TENX – Tenax Therapeutics, Inc. TFFP – TFF Pharmaceuticals, Inc.
TGTX – TG Therapeutics, Inc. THTX – Theratechnologies Inc.
TIL – Instil Bio, Inc.


Financial data and stock pages provided by
Fintel.io